Skin permeation enhancement effects of the gel and whole-leaf materials of Aloe vera, Aloe marlothii and Aloe ferox

Journal of Pharmacy and Pharmacology

Volumn 67, Issue 1, 2015, Pages 96-106

  Fox, Lizelle T ^a   Gerber, Minja ^a   Preez, Jan L Du ^a   Plessis, Jeanetta Du ^a   Hamman, Josias H ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Aloe ferox; Aloe marlothii; Aloe vera; penetration enhancer; skin

Indexed keywords

KETOPROFEN; GEL;

ALOE; ALOE FEROX; ALOE MARLOTHII; ALOE VERA; ARTICLE; CONTROLLED STUDY; DERMOEPIDERMAL JUNCTION; DRUG PENETRATION; FEMALE; GEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MEMBRANE TRANSPORT; PLANT LEAF; PROTON NUCLEAR MAGNETIC RESONANCE; SKIN PENETRATION; STRATUM CORNEUM; TRANSDERMAL DRUG ADMINISTRATION; CUTANEOUS DRUG ADMINISTRATION; DOSE RESPONSE; DRUG EFFECTS; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SKIN; SKIN ABSORPTION;

ADMINISTRATION, CUTANEOUS; ALOE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; GELS; HUMANS; KETOPROFEN; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PLANT LEAVES; SKIN; SKIN ABSORPTION;

EID: 84921534249     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12311     Document Type: Article

References (41)

1. Naik A, et al. Transdermal drug delivery: overcoming the skin's barrier function. Pharm Sci Technol Today 2000; 3: 318-325.
2. Prausnitz MR, Langer R,. Transdermal drug delivery. Nat Biotechnol 2008; 26: 1261-1268.
3. Van Smeden J, et al. The important role of stratum corneum lipids for the cutaneous barrier function. Biochim Biophys Acta 2014; 1841: 295-313.
4. Cornwell PA, et al. Modes of action of terpene penetration enhancers in human skin; differential scanning calorimetry, small-angle X-ray diffraction and enhancer uptake studies. Int J Pharm 1996; 127: 9-26.
5. Barry B,. Transdermal drug delivery. In:, Aulton ME, ed. Pharmaceutics: The Science of Dosage Form Design, 2nd edn. London: Churchill Livingstone, 2002: 499-533.
6. Thomas BJ, Finnin BC,. The transdermal revolution. Drug Discov Today 2004; 9: 697-703.
7. Lane ME,. Skin penetration enhancers. Int J Pharm 2013; 447: 12-21.
8. Fang J-Y, et al. Development of sesquiterpenes from Alpinia oxyphylla as novel skin permeation enhancers. Eur J Pharm Sci 2003; 19: 253-262.
9. Cole L, Heard C,. Skin permeation enhancement potential of Aloe vera and a proposed mechanism of action based upon size exclusion and pull effect. Int J Pharm 2007; 333: 10-16.
10. Loots D, et al. Aloe ferox leaf gel phytochemical content, antioxidant capacity and possible health benefits. J Agric Food Chem 2007; 55: 6891-6896.
11. Eshun K, He Q,. Aloe vera: a valuable ingredient for the food, pharmaceutical and cosmetic industries-a review. Crit Rev Food Sci Nutr 2004; 44: 91-96.
12. Beneke C, et al. In vitro drug absorption enhancement effects of Aloe vera and Aloe ferox. Sci Pharm 2012; 80: 475-486.
13. Ramachandra CT, Rao PS,. Processing of Aloe vera leaf gel: a review. Am J Agric Biol Sci 2008; 3: 502-510.
14. Lebitsa T, et al. In vitro drug permeation enhancement potential of aloe gel materials. Curr Drug Deliv 2012; 9: 297-304.
15. Jambwa T, et al. Matrix forming excipients from natural origin for controlled release matrix type tablets. J Drug Deliv Sci Technol 2011; 21: 433-439.
16. British Pharmacopoeia. Phosphate buffer solution pH 7.4 [online] 2013. http://www.pharmacopoeia.co.uk (accessed 9 September 2013).
17. British Pharmacopoeia. Phosphate buffer solution pH 6.5 [online] 2013. http://www.pharmacopoeia.co.uk (accessed 9 September 2013).
18. Brain KR et al. Investigation of skin permeation in vitro. In: Roberts MS, Walters KA, eds. Dermal Absorption and Toxicity Assessment. New York: Marcel Dekker, 1998: 161-187.
19. Otto A, et al. Effect of emulsifiers and their liquid crystalline structures in emulsions on dermal and transdermal delivery of hydroquinone, salicylic acid and octadecenedioic acid. Skin Pharmacol Physiol 2010; 23: 273-282.
20. Fox LT, et al. Topical and transdermal delivery of l-carnitine. Skin Pharmacol Physiol 2011; 24: 330-336.
21. Pellet MS, et al. Supersaturated solutions evaluated with an in vitro stratum corneum tape stripping technique. Int J Pharm 1997; 151: 91-98.
22. Martin A,. Physical Pharmacy, 4th edn. Baltimore, MD: Lipincott Williams & Wilkins, 1993.
23. Díez-Sales O, et al. A modelistic approach showing the importance of the stagnant aqueous layers in in vitro diffusion studies and in in vitro-in vivo correlations. Int J Pharm 1991; 77: 1-11.
24. Otto A, et al. Effect of penetration modifiers on the dermal and transdermal delivery of drugs and cosmetic active ingredients. Skin Pharmacol Physiol 2008; 21: 326-334.
25. Scheuplein RJ,. Mechanism of percutaneous absorption II. Transient diffusion and the relative importance of various routes of skin penetration. J Invest Dermatol 1967; 48: 79-88.
26. Statsoft, Inc. Statistica: data analysis software system, version 11 [online] 2013. www.statsoft.com (accessed 16 September 2013).
27. Sheskin DJ,. Handbook of Parametric and Nonparametric Statistical Procedures, 2nd edn. Boca Raton, FL: Chapman & Hall/CRC, 2000.
28. Millar N,. Biology statistics made simple using Excel. Sch Sci Rev 2001; 83: 23-34.
29. Dawson B, Trapp RG,. Basic & Clinical Biostatistics, 4th edn. New York: McGraw-Hill, 2004.
30. Chen W, et al. Intestinal drug transport enhancement by Aloe vera. Planta Med 2009; 75: 587-595.
31. Australian Pesticides & Veterinary Medicines Authority (APVMA). Guidelines for the validation of analytical methods for active constituent, agricultural and veterinary chemical products [online] 2004. http://apvma.gov.au/sites/default/files/docs/guideline-69-analytical-methods.pdf (accessed 27 August 2014).
32. Jain PS, et al. Development and validation of the UF-spectrophotometric method for determination of terbinafine hydrochloride in bulk and in formulation. Pharm Methods 2011; 2: 198-202.
33. Kadir R, et al. Delivery of theophylline into excised human skin from alkanoic acid solutions: a 'push-pull' mechanism. J Pharm Sci 1987; 76: 774-779.
34. Heard CM, et al. Skin penetration enhancement of mefenamic acid by ethanol and 1,8-cineole can be explained by the 'pull' effect. Int J Pharm 2006; 321: 167-170.
35. Heard CM, et al. The in vitro delivery of NSAIDs across skin was in proportion to the delivery of essential fatty acids in the vehicle-evidence that solutes permeate skin associated with their solvation cages? Int J Pharm 2003; 261: 165-169.
36. Ballam L, Heard CM,. Pre-treatment with Aloe vera juice does not enhance the in vitro permeation of ketoprofen across skin. Skin Pharmacol Physiol 2007; 23: 113-116.
37. Capasso F, et al. Aloe and its therapeutic use. Phytother Res 1998; 12: S124-S127.
38. Hadgraft J, et al. Skin penetration of topical formulations of ibuprofen 5%: and in vitro comparative study. Skin Pharmacol Appl Skin Physiol 2003; 16: 137-142.
39. Purdon CH et al. Assessment of vehicle effects by skin stripping. In:Smith EW, Maibach HI, eds. Percutaneous Penetration Enhancers, 2nd edn. Boca Raton, FL: CRC Press, 2006: 299-310.
40. Klang V, et al. In vitro vs in vivo tape stripping: validation of the porcine ear model and penetration assessment of novel sucrose stearate emulsions. Eur J Pharm Biopharm 2012; 80: 604-614.
41. Wiechers JW,. The barrier function of the skin in relation to percutaneous absorption of drugs. Pharm Weekbl Sci 1989; 11: 185-198.